BFC Planning’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
BFC Planning's EDIT Position: Q3 2026 in Review
BFC Planning held its Editas Medicine (EDIT) position steady in Q3 2026 at 305 shares worth $784. The position accounts for ﹤0.01% of the portfolio, ranked #3216.
BFC Planning first reported a position in EDIT in Q1 2025 and has held it in 7 quarters since. The position peaked at $988 in Q2 2026. 162 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.
- BFC Planning held 305 shares of Editas Medicine worth $784 as of Q3 2026.
- BFC Planning left its Editas Medicine share count unchanged in Q3 2026.
- Editas Medicine made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3216 holding.
- BFC Planning first reported a position in Editas Medicine in Q1 2025 and has held it in 7 quarters since.
- BFC Planning's Editas Medicine position peaked at $988 in Q2 2026.
- 162 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.